Sanofi

Pfizer to Novartis Seen Gaining as Drought Ends: Health

Pfizer to Novartis Seen Gaining as Drought Ends: Health

Bloomberg

Regeneron shares jump on Sanofi share buy plan

Regeneron shares jump on Sanofi share buy plan

Marketwatch

Sanofi advances after FDA delays rival insulin product

Sanofi advances after FDA delays rival insulin product

The Fly on the Wall

Viehbacher Sees New Sanofi Growing in Diagnostics, Nutrition

Viehbacher Sees New Sanofi Growing in Diagnostics, Nutrition

Bloomberg

Sanofi Misses Earnings But Steps In Right Direction

Sanofi Misses Earnings But Steps In Right Direction

Seeking Alpha

How Big Pharma Gets Bigger, And What Little Pharma Can Do About It

How Big Pharma Gets Bigger, And What Little Pharma Can Do About It

Seeking Alpha

Sanofi's New Diabetes Play Moves Forward

Sanofi's New Diabetes Play Moves Forward

Motley Fool

Isis: FDA Approval Of Kynamro Promises A Bright Future For Company

Isis: FDA Approval Of Kynamro Promises A Bright Future For Company

Seeking Alpha

Opko Health: A Potential $8.3 Billion A Year Company In The Making

Opko Health: A Potential $8.3 Billion A Year Company In The Making

Seeking Alpha

SciClone Announces Product Promotion Agreement Renewal With Key Industry Parnter Sanofi in China

SciClone Announces Product Promotion Agreement Renewal With Key Industry Parnter Sanofi in China

Yahoo/MarketWire